Header Logo

Connection

DAVID G JOHNSON to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications DAVID G JOHNSON has written about Drug Resistance, Neoplasm.
DAVID G JOHNSON
Connection Strength
0.035
Drug Resistance, Neoplasm
  1. XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood. 2010 Jul 15; 116(2):250-3.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.